P04.1 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Type 1 excludes for P04.1 ICD 10 code
- dysmorphism due to warfarin (Q86.2)
- fetal hydantoin syndrome (Q86.1)
Type 2 excludes for P04.1 ICD 10 code
- maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
- maternal use of drugs of addiction (P04.4-)
Codes
- P04.11 Newborn affected by maternal antineoplastic chemotherapy
- P04.12 Newborn affected by maternal cytotoxic drugs
- P04.13 Newborn affected by maternal use of anticonvulsants
- P04.14 Newborn affected by maternal use of opiates
- P04.15 Newborn affected by maternal use of antidepressants
- P04.16 Newborn affected by maternal use of amphetamines
- P04.17 Newborn affected by maternal use of sedative-hypnotics
- P04.1A Newborn affected by maternal use of anxiolytics
- P04.18 Newborn affected by other maternal medication
- P04.19 Newborn affected by maternal use of unspecified medication
Possible back-references that may be applicable or related to P04.1 ICD10 Code:
- P00-P96 Certain conditions originating in the perinatal period
- P00-P04 Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery
- P04 Newborn affected by noxious substances transmitted via placenta or breast milk
Present On Admission (POA Exempt)
P04.1 ICD 10 code is considered exempt from POA reporting